[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, May 30, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on May 23, 2018 ]
[Biostar Announces Receipt of Nasdaq Continued Listing Deficiency Notice XIANYANG, China, May 30, 2018 – Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) (“the Company”), a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China, announced today that on May 23, 2018 ]
[Xinyuan Real Estate Co., Ltd. Announces First Quarterly Dividend for 2018 BEIJING, May 30, 2018 About Xinyuan Real Estate Co., Ltd. http://www.xyre.com Xinyuan Real Estate Co., Ltd. ("Xinyuan") is an NYSE-listed real estate developer and property manager primarily in China and in other countries. In]
[Xinyuan Real Estate Co., Ltd. Announces First Quarterly Dividend for 2018 BEIJING, May 30, 2018 About Xinyuan Real Estate Co., Ltd. http://www.xyre.com Xinyuan Real Estate Co., Ltd. ("Xinyuan") is an NYSE-listed real estate developer and property manager primarily in China and in other countries. In]
[FORM OF SECURITIES PURCHASE AGREEMENT 证券购买协议 Agreement Company Purchaser Purchasers This SECURITIES PURCHASE AGREEMENT (the “ 本协议 协议 公司 附录B 购买人 本证券购买协议(“ RECITALS 前言 证券法 规则S 鉴于，根据美国证监会在修订的1933年证券法（“ “Business WHEREAS, the Company is offering certain shares of its common stock, par value $0.001 per s]
[FORM OF SECURITIES PURCHASE AGREEMENT 证券购买协议 Agreement Company Purchaser Purchasers This SECURITIES PURCHASE AGREEMENT (the “ 本协议 协议 公司 附录B 购买人 本证券购买协议(“ RECITALS 前言 证券法 规则S 鉴于，根据美国证监会在修订的1933年证券法（“ “Business WHEREAS, the Company is offering certain shares of its common stock, par value $0.001 per s]
[Use these links to rapidly review the document PROXY STATEMENT OF THE COMPANY , 2018 Shareholders of iKang Healthcare Group, Inc. Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of iKang Healthcare Group, Inc. (the "Company") to be held on , 201]
